Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JWK002 in X-linked Retinoschisis
NCT06345898Phase 1Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2023
- Primary completion
- Nov 2033
- Modality
- Gene Editing, Gene Silencing, Viral Vectors
- Countries
- 1
01
Overview
Phase 1, single-blind trial of jwk002 in X-linked retinoschisis (XLRS) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Participants With Ocular and Non-ocular Adverse Events and Serious Adverse Events at 12 months. Started Nov 2023; status: recruiting.
02
Drugs
jwk002
03
Conditions
X-linked retinoschisis (XLRS)
Beyond the preview
Go deeper on NCT06345898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06345898.